Neuromuscular Disease News and Research

RSS
Cancer cells maintain rapid proliferation due to PK-M2 enzyme

Cancer cells maintain rapid proliferation due to PK-M2 enzyme

People with Parkinson's can benefit from computer-based physical therapy games

People with Parkinson's can benefit from computer-based physical therapy games

FARA announces 2011 Ataxian Athlete Initiative grant recipients

FARA announces 2011 Ataxian Athlete Initiative grant recipients

FDA approves NeuRx Diaphragm Pacing System to treat ALS

FDA approves NeuRx Diaphragm Pacing System to treat ALS

Researchers identify common genetic mutation for ALS, frontotemporal dementia

Researchers identify common genetic mutation for ALS, frontotemporal dementia

Researchers’ discovery may revolutionize treatment of Lou Gehrig’s disease

Researchers’ discovery may revolutionize treatment of Lou Gehrig’s disease

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Walgreens, MDA team up to offer free seasonal flu shots

Walgreens, MDA team up to offer free seasonal flu shots

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy

NIH/NINDS awards AMRI to develop pre-clinical drug candidate for spinal muscular atrophy

New application for understanding peripheral nervous system

New application for understanding peripheral nervous system

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

U.S. FDA approves generic Levaquin for treatment of bacterial infections

U.S. FDA approves generic Levaquin for treatment of bacterial infections

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy

Neuralstem to present HSSC Phase I trial data in amyotrophic lateral sclerosis at AAN meeting

Neuralstem to present HSSC Phase I trial data in amyotrophic lateral sclerosis at AAN meeting

Enzo Life Sciences introduces ELISA system to detect SMN protein

Enzo Life Sciences introduces ELISA system to detect SMN protein

Hospital for Special Care announces opening of comprehensive heart failure in-patient unit in Connecticut

Hospital for Special Care announces opening of comprehensive heart failure in-patient unit in Connecticut

MDA grants $13.5 million to support new research treatments for neuromuscular diseases

MDA grants $13.5 million to support new research treatments for neuromuscular diseases

Muscular Dystrophy Association awards 44 research grants totaling $13.5 million

Muscular Dystrophy Association awards 44 research grants totaling $13.5 million

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker

CMD co-founder receives Prize4Life award for discovery of new ALS biomarker